Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Producers Of Innovative Drugs, Medical Devices Slated To Gain From China's Drive To Expand Hospitals, Insurance Coverage In 2011

This article was originally published in PharmAsia News

Executive Summary

BEIJING - Developers of innovative drugs and biopharmaceuticals, along with medical device makers, could all benefit as China's government steps up plans to expand health insurance coverage and rural medical facilities across the nation in 2011, according to a prominent analyst who monitors the Chinese healthcare system and reforms

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC076375

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel